A carregar...
Exploring an Integrative Therapy for Treating COVID-19: A Randomized Controlled Trial
OBJECTIVES: To develop a new Chinese medicine (CM)-based drug and to evaluate its safety and effect for suppressing acute respiratory distress syndrome (ARDS) in COVID-19 patients. METHODS: A putative ARDS-suppressing drug Keguan-1 was first developed and then evaluated by a randomized, controlled t...
Na minha lista:
| Publicado no: | Chin J Integr Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Berlin Heidelberg
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7364292/ https://ncbi.nlm.nih.gov/pubmed/32676976 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11655-020-3426-7 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|